AVTR
Avantor, Inc.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$14.97
−1.45%Year over year
Reported trailing growth
- Revenue
- -1.6%
- EBITDA
- -91.1%
- EBIT
- —
- EPS
- —
- Free cash flow
- -18.2%
- Operating cash flow
- -12.4%
Forward estimates
Based on analyst estimates
- Revenue
- +1.5%
- EBITDA
- +910.4%
- EPS
- +203.0%
Three-year CAGR
- Revenue
- -4.5%
- EBITDA
- -55.0%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -11.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026